NSW Health Pathology was formed in 2012. It protects and enhances the health, safety and wellbeing of our communities at all stages of life and is a trusted partner and committed to excellence in quality, safety and innovation. It leads the way in training, education, research and policy creation to meet the diverse, evolving needs of its communities.

NSW Health Pathology Point of Care Testing is the world’s largest accredited managed service with more than 750 point of care devices installed over 200 metropolitan, regional and rural hospital settings. Point of Care testing groups include: coronary, diabetes, infection, general health status, blood gas/acid base, reproduction.

NSW Health Pathology’s key capability areas include: Scientific IP; Digital solutions development (IT development); Patient testing – hospitals, mobile, community, companion diagnostics; Technology evaluation; Clinical trial services; R&D; Prototype manufacture.